The country is closely watching how the battle over abortion medication unfolds in federal courts. It follows a Texas judge’s decision to overturn FDA approval of the mifepristone. But there’s also growing concern over what that ruling could mean for the drug approval process in general. Amna Nawaz discussed what’s at stake with Dr. Joshua Sharfstein, the former FDA principal deputy commissioner.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
TikTok: https://www.tiktok.com/@pbsnews
Twitter: https://www.twitter.com/newshour
Instagram: https://www.instagram.com/newshour
Facebook: https://www.pbs.org/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
